×
For best experience we recommend to activate Javascript in your browser.
CEACAM3 antibody
The Mouse Monoclonal anti-CEACAM3 antibody (ABIN7836536) specifically detects CEACAM3 in WB and FACS.
The antibody is reactive with Human and Rat samples.
Catalog No. ABIN7836536
$553.85
Plus shipping costs $50.00
Delivery in 1 to 2 Business Days
Quick Overview for CEACAM3 antibody (ABIN7836536)
Target
See all CEACAM3 Antibodies
CEACAM3
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3))
Reactivity
All reactivities for CEACAM3 antibodies
Human, Rat
Host
All hosts for CEACAM3 antibodies
Mouse
Clonality
All clonalities for CEACAM3 antibodies
Monoclonal
Conjugate
All conjugates for CEACAM3 antibodies
This CEACAM3 antibody is un-conjugated
Application
All applications for CEACAM3 antibodies
Western Blotting (WB), Flow Cytometry (FACS)
Product Details anti-CEACAM3 Antibody
(hide)
Purpose
Mouse monoclonal to CD66d
Specificity
Recognizes endogenous levels of CD66d protein
Purification
This antibody is purified through a protein G column.
Immunogen
Recombinant fusion protein of human CD66d expressed in E. Coli
Alternatives
(show)
Application Details
(hide)
Application Notes
WB (1/500 - 1/1000), FC (1/100 - 1/200)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Liquid in PBS, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
Target Details for CEACAM3
(hide)
Target
CEACAM3
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3))
Alternative Name
CEACAM3
Background
CD66D, CGM1, CarcinoembryonIC, antigen-related cell adhesion molecule 3, CarcinoembryonIC, antigen CGM1, CD66d
Gene ID
1084
UniProt
P40198
Recently viewed
(hide)
You are here:
Homepage
anti-CEACAM3 antibody (ABIN7836536)
Chat with us , powered by LiveChat